...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: New Publication

"Our results support clinical evaluation of apabetalone to treat COVID-19 and post-COVID syndrome regardless of the SARS-CoV-2 variant."

Last chance Don!  You now have ZERO excuses for not getting funding!  Anyone with this endoresement  who can't attract partners or funding for immediate trials should resign immediately, or risk being investigated...
 

JMHO

Share
New Message
Please login to post a reply